Amgen (AMGN) reported its Q2 2026 financial results on August 4, 2026, after market close. The company announced an EPS of 6.29 USD, beating the analyst estimate of 5.61 USD by 12.2%. Revenue reached 10054 million USD for the quarter, and the stock price reacted with an increase of 4.57% after the release.
Generated automatically from our data — as of August 12, 2026
Key figures at a glance
Estimate (EPS): 5.61 USD
Reported (EPS): 6.29 USD
Price reaction: +4.6%
Frequently asked questions
Did Amgen beat or miss earnings-per-share expectations?
Amgen beat the analyst estimate of 5.61 USD earnings per share (Q2 2026) by 12.2%, reporting 6.29 USD.
How did Amgen stock react to the earnings report?
Amgen stock rose 4.6% on the trading day following the release.
What was Amgen's revenue in Q2 2026?
Amgen reported revenue of 10,054M USD in Q2 2026.